Evidence map›Paper›PMID 40052502›Full record

ArticleAllergy2025

The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3

Andrés de la Rocha-Muñoz, Cristina Benito-Villalvilla, David Olivares, Sofía Sirvent, Miguel A García-Brenes, Alba Angelina, Leticia Martín-Cruz, Javier Cuesta, Paolo Tassinari, Xavier Jaumont and 2 more

Abstract read
In one paragraph

Article in Allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrés de la Rocha-MuñozDepartment of Biochemistry and Molecular Biology, School of Chemistry, Complutense University, Madrid, Spain.ORCID https://orcid.org/0000-0003-0168-7943
Cristina Benito-VillalvillaDepartment of Biochemistry and Molecular Biology, School of Chemistry, Complutense University, Madrid, Spain.ORCID https://orcid.org/0000-0002-5544-0199
David OlivaresInflammatory Bowel Disease Unit, Gastroenterology Department, Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos [IdISSC], Madrid, Spain.ORCID https://orcid.org/0000-0003-3506-7355
Sofía SirventDepartment of Biochemistry and Molecular Biology, School of Chemistry, Complutense University, Madrid, Spain.ORCID https://orcid.org/0000-0003-0050-8579
Miguel A García-BrenesInflammatory Bowel Disease Unit, Gastroenterology Department, Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos [IdISSC], Madrid, Spain.ORCID https://orcid.org/0009-0006-2133-4984
Alba AngelinaDepartment of Biochemistry and Molecular Biology, School of Chemistry, Complutense University, Madrid, Spain.ORCID https://orcid.org/0000-0001-5282-9767
Leticia Martín-CruzDepartment of Biochemistry and Molecular Biology, School of Chemistry, Complutense University, Madrid, Spain.ORCID https://orcid.org/0000-0002-2546-1183
Javier CuestaAllergy Department, Fundación Jiménez Díaz, Madrid, Spain.
Paolo TassinariNovartis Pharma AG, Basel, Switzerland.ORCID https://orcid.org/0000-0003-0205-1795
Xavier JaumontNovartis Pharma AG, Basel, Switzerland.ORCID https://orcid.org/0000-0002-4197-1634
Carlos TaxoneraInflammatory Bowel Disease Unit, Gastroenterology Department, Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos [IdISSC], Madrid, Spain.ORCID https://orcid.org/0000-0001-9166-7350
Oscar PalomaresDepartment of Biochemistry and Molecular Biology, School of Chemistry, Complutense University, Madrid, Spain.ORCID https://orcid.org/0000-0003-4516-0369

Funding

Ministerio de Ciencia e InnovaciónMinisterio de UniversidadesNovartis Pharma
6 · The paper itself

Abstract

backgroundA causal relationship between Crohn's disease (CD) and asthma is reported, but the underlying mechanisms are not fully understood. We sought to investigate the role of IgE and IgE-mediated pathways in the pathophysiology of CD.

methods20 CD patients, 10 allergic patients without inflammatory bowel disease, and 10 healthy donors (HD) were included in the study. Total serum IgE was quantified by ELISA. Circulating IgE

resultsCD patients, similar to allergic non-CD patients, displayed significantly higher numbers of circulating IgE

conclusionsIgE might play an unprecedented role in CD by impairing the capacity of pDCs to generate Tregs, which could represent a novel mechanism contributing to CD to be exploited for alternative therapeutic interventions.

Indexed as

Crohn DiseaseDendritic CellsForkhead Transcription FactorsImmunoglobulin ET-Lymphocytes, RegulatoryAdultFemaleHumansMaleMiddle AgedReceptors, IgEYoung AdultForkhead Transcription FactorsFOXP3 protein, humanImmunoglobulin EReceptors, IgECrohn's diseaseIgEplasmacytoid dendritic cellsregulatory T cells

Identifiers

PMID40052502
PMCPMC12368764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.